Turbocharged Sequencing For Your High-Volume Research
Clinical Enterprise is excited to announce the addition of the cutting-edge DNBSEQ-T7 sequencing platform to our portfolio. We have expanded our capabilities in multiomic research services, and we are now a proud member of Complete Genomics’ Sequencing Service Provider Program.
Clinical Enterprise already provides whole genome sequencing, low-pass whole genome sequencing (lpWGS), spatial-resolved transcriptomics, and single-cell sequencing. The addition of the DNBSEQ-T7 platform allows us to deliver these same high-quality services on a new, innovative system, giving us greater flexibility to tailor solutions to a wider range of project needs.
By integrating the DNBSEQ-T7 into our operations, Clinical Enterprise will empower researchers with even more options for projects of all sizes, while maintaining competitive pricing and faster turnaround times.
Our collaboration with Complete Genomics underscores Clinical Enterprise’s commitment to bridging the gap between discovery and innovation, leveraging advanced sequencing technologies to meet the evolving needs of the research community.
You can read Complete Genomics’ Press Release here.
